HomeCASI • NASDAQ
add
CASI Pharmaceuticals Inc
Previous close
$2.75
Day range
$2.59 - $2.80
Year range
$1.85 - $8.48
Market cap
34.98M USD
Avg Volume
44.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 6.87M | -54.95% |
Operating expense | 7.52M | -53.27% |
Net income | -6.06M | 69.01% |
Net profit margin | -88.09 | 31.20% |
Earnings per share | -0.34 | — |
EBITDA | -2.52M | 40.07% |
Effective tax rate | 1.36% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 30.77M | -40.06% |
Total assets | 75.27M | -21.79% |
Total liabilities | 51.10M | 74.40% |
Total equity | 24.16M | — |
Shares outstanding | 12.99M | — |
Price to book | 1.52 | — |
Return on assets | -11.57% | — |
Return on capital | -18.05% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -6.06M | 69.01% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1991
Headquarters
Website
Employees
176